RDC8 codes for an adenosine A2 receptor with physiological constitutive activity

Biochemical and Biophysical Research Communications
C MaenhautS N Schiffmann

Abstract

The cDNA of an unidentified recently cloned G protein-coupled receptor, RDC8, has been expressed in Y1 adrenal cells, in dog thyrocytes in primary culture and in Xenopus oocytes. In all these systems this resulted in the activation of adenylyl cyclase and of the cyclic AMP cascade in the absence of any added external signal. However, this physiologically constitutive activator was inhibited by adenosine deaminase and by inhibitors of the adenosine A2 receptor. Cos 7 cells transfected with RDC8 cDNA constructs acquired binding characteristics of an adenosine A2 receptor. Moreover, RDC8 mRNA and adenosine A2 receptors display a very similar distribution in the brain. RDC8 therefore codes for an A2 adenosine receptor. Whether the physiologically constitutive activation of this receptor is entirely explained by endogeneously produced adenosine is as yet unknown.

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P C RossK R Lynch
Feb 14, 1990·Biochemical and Biophysical Research Communications·M J AbramowiczD Christophe
Dec 22, 1989·Science·M ParmentierG Vassart
Jan 1, 1989·Neuroscience·S P Alexander, M Reddington
Apr 1, 1974·Analytical Biochemistry·Y SalomonM Rodbell
Sep 25, 1984·Nucleic Acids Research·P A Krieg, D A Melton

❮ Previous
Next ❯

Citations

Jan 1, 1996·Drug Development Research·A Michiel van Rhee, Kenneth A Jacobson
Jun 1, 1992·Developmental Dynamics : an Official Publication of the American Association of Anatomists·M R BlackburnT B Knudsen
Mar 1, 1993·Drug Development Research·Kenneth A JacobsonGary L Stiles
Sep 1, 1992·Medicinal Research Reviews·P J van GalenK A Jacobson
Aug 25, 2001·Biochemical and Biophysical Research Communications·K H LeeY S Lee
Nov 1, 1993·Cardiovascular Drugs and Therapy·C Sylvén
Nov 1, 1994·Agents and Actions·D L Marquardt, L L Walker
Mar 2, 1994·Biochemical Pharmacology·L E Brackett, J W Daly
Aug 28, 1995·Brain Research·M Hillefors-BerglundG von Euler
Sep 7, 1993·European Journal of Pharmacology·S Pirotton, J M Boeynaems
Jan 11, 1996·European Journal of Pharmacology·S H Kafka, R Corbett
Sep 1, 1993·Pharmaceutica acta Helvetiae·C E Müller, T Scior
Mar 1, 1995·Pharmaceutica acta Helvetiae·G Burnstock
Jan 1, 1991·Pharmacology & Therapeutics·T Jackson
Jan 1, 1994·Pharmacology & Therapeutics·M P Abbracchio, G Burnstock
Sep 1, 1991·Trends in Pharmacological Sciences·J LindenK R Lynch
Nov 1, 1993·Trends in Pharmacological Sciences·A Mills, M J Duggan
Oct 1, 1993·Trends in Pharmacological Sciences·M G Collis, S M Hourani
Sep 1, 1992·Brain Research. Molecular Brain Research·T J FurlongJ Shine
Feb 1, 1996·Progress in Neurobiology·A M Sebastião, J A Ribeiro
Apr 1, 1994·Molecular and Cellular Endocrinology·C LedentJ E Dumont
Sep 16, 1991·Neuroscience Letters·S N SchiffmannJ J Vanderhaeghen
Aug 20, 1993·Neuroscience Letters·S N Schiffmann, J J Vanderhaeghen
Dec 1, 1992·Neuroscience·S FerréB B Fredholm
Sep 15, 1994·European Journal of Pharmacology·J O Schiele, U Schwabe
Feb 1, 1993·Current Opinion in Biotechnology·M Williams
Jun 1, 1991·Current Opinion in Neurobiology·J Bockaert
Jun 24, 2004·Bulletin of Mathematical Biology·Maykel Pérez González, Maria del Carmen Terán Moldes
Aug 31, 1992·Biochemical and Biophysical Research Communications·K D PierceJ Shine
Sep 16, 1999·Biochemical Pharmacology·I Tatsis-Kotsidis, B F Erlanger
Mar 14, 2002·European Journal of Pharmacology·Elizabeth González-BenítezEnrique Piña

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.